StockData
MannKind Corp logo

MannKind Corp (MNKD) stock

MNKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30119% above fair value
$4.07+0.00 (0.00%)

Close on Nov 18, 2026Market cap $1.31BP/E –Yield –

MannKind shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

MannKind's shares outstanding was 309M at Jun 30, 2026. For fiscal 2025 it was 314M, up 10.7% from the year before. Over ten years it grew 14.5% a year on average. The highest annual figure on record is 314M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025314M+10.7%
FY2024Dec 31, 2024284M+6.3%
FY2023Dec 31, 2023267M+3.9%
FY2022Dec 31, 2022257M+3.1%
FY2021Dec 31, 2021249M+12.0%
FY2020Dec 31, 2020223M+13.8%
FY2019Dec 31, 2019196M+35.7%
FY2018Dec 31, 2018144M+38.3%
FY2017Dec 31, 2017104M+13.2%
FY2016Dec 31, 201692M+13.4%
FY2015Dec 31, 201581M+5.4%
FY2014Dec 31, 201477M+28.6%
FY2013Dec 31, 201360M+65.7%
FY2012Dec 31, 201236M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026309M-0.7%
Q1 FY2026Mar 31, 2026308M-3.9%
Q4 FY2025Dec 31, 2025316M+8.7%
Q3 FY2025Sep 30, 2025312M+9.5%
Q2 FY2025Jun 30, 2025311M+14.1%
Q1 FY2025Mar 31, 2025321M-1.2%
Q4 FY2024Dec 31, 2024291M+8.0%
Q3 FY2024Sep 30, 2024285M-12.1%
Q2 FY2024Jun 30, 2024273M+2.8%
Q1 FY2024Mar 31, 2024325M+23.0%
Q4 FY2023Dec 31, 2023270M+2.4%
Q3 FY2023Sep 30, 2023324M+24.9%
Q2 FY2023Jun 30, 2023266M+4.7%
Q1 FY2023Mar 31, 2023264M+4.8%
Q4 FY2022Dec 31, 2022263M+4.9%
Q3 FY2022Sep 30, 2022259M+3.8%
Q2 FY2022Jun 30, 2022254M+1.7%
Q1 FY2022Mar 31, 2022252M+2.1%
Q4 FY2021Dec 31, 2021251M+7.0%
Q3 FY2021Sep 30, 2021250M+8.8%
Q2 FY2021Jun 30, 2021249M+16.6%
Q1 FY2021Mar 31, 2021247M+16.1%
Q4 FY2020Dec 31, 2020235M+13.5%
Q3 FY2020Sep 30, 2020230M+14.9%
Q2 FY2020Jun 30, 2020214M+13.7%
Q1 FY2020Mar 31, 2020212M+13.4%
Q4 FY2019Dec 31, 2019207M+28.1%
Q3 FY2019Sep 30, 2019200M+30.1%
Q2 FY2019Jun 30, 2019188M+34.3%
Q1 FY2019Mar 31, 2019187M+55.0%
Q4 FY2018Dec 31, 2018161M+38.6%
Q3 FY2018Sep 30, 2018154M+46.7%
Q2 FY2018Jun 30, 2018140M+40.2%
Q1 FY2018Mar 31, 2018121M+26.3%
Q4 FY2017Dec 31, 2017116M+20.7%
Q3 FY2017Sep 30, 2017105M+8.4%
Q2 FY2017Jun 30, 2017100M–
Q1 FY2017Mar 31, 201796M–
Q4 FY2016Dec 31, 201697M–
Q3 FY2016Sep 30, 201697M–

More MannKind figures

See a number that looks wrong?